Answers are grounded in this paper and cite their sources.
Background: Symptoms of obsessive-compulsive disorder (OCD), contamination type has increased due to the COVID-19 pandemic. However, whether these symptoms would decrease after introducing the vaccines is unknown. Thus, this study examined the prevalence of COVID-19-related OCD among young adults who had never been diagnosed with a psychiatric disorder after fully controlling the pandemic. Methods: A sample of 351 young adults from all Saudi regions, whose ages ranged from 18-year-old to 25-year-old, were collected virtually in March and April 2022, via using an Arabic online survey that was distributed through social networks which included socio-demographic characteristics, COVID-19-related items, and COVID-19-related obsessions and compulsions assessment items. Results: Most of the participants were females (83.2%), had received the 3 rd dose of the vaccine (69.80%), and reported having no obsessive thoughts or compulsive behaviors related to COVID-19 (91.5%, 96.6%). Despite this, males still had lower scores of OCD symptoms related to COVID-19 compared to females (9.98 vs. 14.29). The results also show that the mean scores of OCD symptoms decreased with each vaccine shot, 16.80 ± 18.91, 14.12 ± 10.85, and 13.27 ± 11.27 for the 1 st , 2 nd , and 3 rd doses, respectively. Conclusion: Introducing the COVID-19 vaccine may reduce the onsets of obsessions and compulsive behaviors related to contamination. Some compulsive behaviors might be considered the new normal as they do not cause functional impairment.
No takes yet. Share an insight, caveat, or question.
Aljwiser et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: